Head-to-head · Value Score
CoreAge Rx vs Lyfe Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Lyfe Rx a 66. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameLyfe Rx
#310 · Grade C · Watch List
Est. first month
From $225/mo (compounded)
Save ~83% vs brand-nameFDA warning letter. The FDA issued Lyfe Rx a warning letter in September 2025. Check it on the FDA database.
Get this deal Full Lyfe Rx review →The verdict
CoreAge Rx takes it on Value Score, 93 to 66 — an est. $99/mo first month, with no teaser step-up baked in. Lyfe Rx isn't out of it: Someone weighing a mid-priced program who has read the FDA disclosure on this page first.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Lyfe Rx |
|---|---|---|
| Value Score | 93 (A+) | 66 (C) |
| Est. first month | $99/mo | From $225/mo (compounded) |
| Save vs brand-name | ~89% | ~83% |
| Semaglutide | $99/mo | From $225/mo (compounded) |
| Tirzepatide | $149/mo | From $299/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Lyfe Rx
Lyfe Rx is a storefront selling compounded semaglutide at $225 and tirzepatide at $299 a month beside testosterone therapy, NAD+, at-home lab panels and its own supplement line.
Why it's a deal
- Both molecules are priced plainly on the storefront - $225 semaglutide and $299 tirzepatide - with no intake required to see them
- Displays a LegitScript certification badge linking to LegitScript's own site, and states it works only with pharmacies licensed at federal, state and local level
- HSA and FSA qualified, with free shipping and ongoing provider support included in the price
The fine print
- The FDA issued this company a warning letter dated 9 September 2025, and the letter is public in the FDA's warning-letter database
- The LegitScript badge is the seller's own claim on its own page; we have not independently confirmed the certification is current
- Also sells non-prescription supplements beside the prescription products, including a "Tirzepatide Weight Loss Supplement" and a "Lipo Burn" line, which blurs what is prescribed and what is not
- A Shopify storefront with fewer clinical-infrastructure signals than the better-documented programs here
- The states it serves are not published
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Lyfe Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.